EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol

Josh Martin, Fatemeh Gholamali Nezhad, Alice Rueda, Gyu Hee Lee iD, Colleen E Charlton iD, Milad Soltanzadeh, Karim S Ladha, Sridhar Krishnan, Andreea O Diaconescu, Venkat Bhat iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0308413 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Josh Martin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Psychiatry Program, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Ketamine, Depressive Disorder, Treatment-Resistant, Electroencephalography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Frontiers in Research Fund, CAMH Discovery Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketamine has recently attracted considerable attention for its rapid effects on patients with major depressive disorder, including treatment-resistant depression (TRD). Despite ketamine’s promising results in treating depression, a significant number of patients do not respond to the treatment, and predicting who will benefit remains a challenge. Although its antidepressant effects are known to be linked to its action as an antagonist of the N-methyl-D-aspartate (NMDA) receptor, the precise mechanisms that determine why some patients respond and others do not are still unclear.

Objective

This study aims to understand the computational mechanisms underlying changes in the auditory mismatch negativity (MMN) response following treatment with intravenous ketamine. Moreover, we aim to link the computational mechanisms to their underlying neural causes and use the parameters of the neurocomputational model to make individual treatment predictions.

Methods

This is a prospective study of 30 patients with TRD who are undergoing intravenous ketamine therapy. Prior to 3 out of 4 ketamine infusions, EEG will be recorded while patients complete the auditory MMN task. Depression, suicidality, and anxiety will be assessed throughout the study and a week after the last ketamine infusion. To translate the effects of ketamine on the MMN to computational mechanisms, we will model changes in the auditory MMN using the hierarchical Gaussian filter, a hierarchical Bayesian model. Furthermore, we will employ a conductance-based neural mass model of the electrophysiological data to link these computational mechanisms to their neural causes.

Conclusion

The findings of this study may improve understanding of the mechanisms underlying response and resistance to ketamine treatment in patients with TRD. The parameters obtained from fitting computational models to EEG recordings may facilitate single-patient treatment predictions, which could provide clinically useful prognostic information.

Trial registration

Clinicaltrials.gov NCT05464264 . Registered June 24, 2022.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineDepressive Disorder, Treatment-ResistantElectroencephalographyHumansAdultProspective StudiesAntidepressive AgentsMaleFemaleEvoked Potentials, AuditoryMajor Depressive DisorderTreatment OutcomeReceptors, N-Methyl-D-AspartateMiddle AgedYoung Adult

Substanzen

KetamineAntidepressive AgentsReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Interventional Psychiatry Program, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
  • Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Anesthesia, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
  • Department of Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, Ontario, Canada.
  • Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Gyu Hee Lee, Colleen E Charlton, Venkat Bhat

Förderung

  • New Frontiers in Research Fund
  • CAMH Discovery Fund

Zitieren

APA

Martin, J., Gholamali Nezhad, F., Rueda, A., Lee, G. H., Charlton, C. E., Soltanzadeh, M., Ladha, K. S., Krishnan, S., Diaconescu, A. O., & Bhat, V. (2024). Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0308413

Vancouver

Martin J, Gholamali Nezhad F, Rueda A, Lee GH, Charlton CE, Soltanzadeh M, et al. Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0308413

BibTeX
@article{Martin2024,
  author = {Martin, Josh and Gholamali Nezhad, Fatemeh and Rueda, Alice and Lee, Gyu Hee and Charlton, Colleen E and Soltanzadeh, Milad and Ladha, Karim S and Krishnan, Sridhar and Diaconescu, Andreea O and Bhat, Venkat},
  title = {Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0308413}
}
Kostenlos starten →